These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 35107073)
1. Response of recalcitrant generalized morphea to intravenous immunoglobulins (IVIg): three cases and a review of the literature. Kromer C; Mitterlechner L; Langer N; Schön MP; Mössner R Eur J Dermatol; 2021 Dec; 31(6):822-829. PubMed ID: 35107073 [TBL] [Abstract][Full Text] [Related]
2. Treatment of recalcitrant generalized morphea with mycophenolate mofetil and intravenous immunoglobulin. Küçükoğlu R; Yılmaz Z; Kutlay A Dermatol Ther; 2018 Sep; 31(5):e12674. PubMed ID: 30133962 [No Abstract] [Full Text] [Related]
3. A Case of Bullous Morphea Resistant to Methotrexate and Phototherapy Successfully Treated With Mycophenolate Mofetil. Cuellar-Barboza A; Alberto Cardenas-De La Garza J; Daniel Villarreal-Villarreal C; Ocampo-Candiani J; Gomez-Flores M; Welsh O; Herz-Ruelas ME J Drugs Dermatol; 2018 Oct; 17(10):1123-1125. PubMed ID: 30365594 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea. Arthur M; Fett NM; Latour E; Jacobe H; Kunzler E; Florez-Pollack S; Houser J; Sharma S; Prasad S; Femia A; Stern MJ; Pappas-Taffer LK; Gaffney R; Fernandez AP; Knabel D; Cardones AR; Leung N; Laumann A; Yu JM; Zhao J; Vleugels RA; Tkachenko E; Lo K JAMA Dermatol; 2020 May; 156(5):521-528. PubMed ID: 32236497 [TBL] [Abstract][Full Text] [Related]
5. Morphea and Eosinophilic Fasciitis: An Update. Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481 [TBL] [Abstract][Full Text] [Related]
6. Therapy of childhood generalized morphea: case reports and reviews of the literature of Japanese cases. Kawashima H; Watanabe C; Kashiwagi Y; Sato S; Ioi H; Sasamoto M; Takekuma K; Ookubo Y; Ooi T; Hoshika A Pediatr Int; 2006 Jun; 48(3):342-5. PubMed ID: 16732809 [No Abstract] [Full Text] [Related]
7. Study about evaluation of efficacy of methotrexate in localized scleroderma using ultrasonography. Zhang F; Li J; Zhao Q; Liu H; Zhang F Skin Res Technol; 2023 Mar; 29(3):e13300. PubMed ID: 36973989 [TBL] [Abstract][Full Text] [Related]
8. Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach. Schanz S; Henes J; Ulmer A; Kötter I; Fierlbeck G; Claussen CD; Horger M AJR Am J Roentgenol; 2013 Apr; 200(4):W376-82. PubMed ID: 23521481 [TBL] [Abstract][Full Text] [Related]
9. Update on the classification and treatment of localized scleroderma. Bielsa Marsol I Actas Dermosifiliogr; 2013 Oct; 104(8):654-66. PubMed ID: 23948159 [TBL] [Abstract][Full Text] [Related]
10. Pediatric morphea (localized scleroderma): review of 136 patients. Christen-Zaech S; Hakim MD; Afsar FS; Paller AS J Am Acad Dermatol; 2008 Sep; 59(3):385-96. PubMed ID: 18571769 [TBL] [Abstract][Full Text] [Related]
11. Low effectiveness of methotrexate in the management of localised scleroderma (morphea) based on an ultrasound activity score. Vera-Kellet C; Meza-Romero R; Moll-Manzur C; Ramírez-Cornejo C; Wortsman X Eur J Dermatol; 2021 Dec; 31(6):813-821. PubMed ID: 35107072 [TBL] [Abstract][Full Text] [Related]
12. Atypical generalized morphea-like scleroderma presenting deep sclerosis on the fingers. Taniguchi Y; Okazaki M; Kagawa T; Nakajima K; Nakajima H; Terada Y Mod Rheumatol; 2011 Apr; 21(2):232-4. PubMed ID: 21113639 [No Abstract] [Full Text] [Related]
14. Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review. Soh HJ; Samuel C; Heaton V; Renton WD; Cox A; Munro J Rheumatol Int; 2019 May; 39(5):933-941. PubMed ID: 30838436 [TBL] [Abstract][Full Text] [Related]
15. Generalized morphea with peripheral eosinophilia, fasciitis and myositis. King DF; Dore RK; Gilbert DJ; Gurevitch AW; Hirose FM Int J Dermatol; 1980 Apr; 19(3):149-53. PubMed ID: 7190134 [TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421 [TBL] [Abstract][Full Text] [Related]
17. Clinical experience with biologic treatment in resistant eosinophilic fasciitis: Case reports and review of the literature. Erez D; Shoenfeld Y; Natour A; Dovrish Z; Tayer-Shifman OE; Levy Y Medicine (Baltimore); 2021 Apr; 100(13):e25359. PubMed ID: 33787639 [TBL] [Abstract][Full Text] [Related]